QQQ

DIA

SPY

TLT

GLD

BTC/USD

QQQ

DIA

SPY

TLT

GLD

BTC/USD

Range

447.59 - 457.71

Vol / Avg.

3.1M/2.6M

Div / Yield

5.8/1.29%

52 Wk

299.6 - 452.64

Mkt Cap

428.7B

Payout Ratio

33.5

Open

450.49

P/E

27.88

EPS

4.33

Shares

942.9M

Outstanding

942.9M

Total Float

939M

Analyst Ratings

Wells Fargo Maintains Overweight on UnitedHealth Group, Raises Price Target to $520

Benzinga - 1 day ago

Why UnitedHealth Shares Are Rising

Benzinga - 6 days ago

Shares of healthcare providers and insurers are trading higher in sympathy with Anthem, which gained after reporting better-than-expected Q3 results and raising FY21 guidance.

Benzinga - 6 days ago

Morgan Stanley Maintains Overweight on UnitedHealth Group, Raises Price Target to $499

Benzinga - Oct 15, 2021, 9:50AM

Oppenheimer Maintains Outperform on UnitedHealth Group, Raises Price Target to $475

Benzinga - Oct 15, 2021, 7:57AM

Credit Suisse Maintains Outperform on UnitedHealth Group, Raises Price Target to $495

Benzinga - Oct 15, 2021, 7:55AM

RBC Capital Maintains Outperform on UnitedHealth Group, Raises Price Target to $476

Benzinga - Oct 15, 2021, 7:35AM

UnitedHealth Group shares are trading higher after the company reported better-than-expected Q3 EPS and sales results and raised FY21 adjusted EPS guidance.

Benzinga - Oct 14, 2021, 8:53AM

UnitedHealth Shares Gain On Q3 Earnings Beat, Raised FY21 Outlook

Benzinga - Oct 14, 2021, 7:22AM

UnitedHealth Group Raises FY21 Adj EPS Guidance From $18.30-$18.80 To $18.65-$18.90 Vs. $18.75 Est.

Benzinga - Oct 14, 2021, 6:00AM

UnitedHealth Group Q3 Adj. EPS $4.52 Beats $4.41 Estimate, Sales $72.30B Beat $71.19B Estimate

Benzinga - Oct 14, 2021, 5:58AM

UPDATE: SVB Leerink On UnitedHealth Outperform Initiation: Firm Sees Accelerating Themes Into FY22 To Further Push Up Valuation Multiples Given Co.'s Diverse & Attractive Global Growth Platform; Highlights Optum As Primary Growth Driver & Differentiator

Benzinga - Sep 27, 2021, 1:21PM

Why Did SVB Leerink Initiate Humana With Outperform?

Benzinga - Sep 27, 2021, 10:40AM

UPDATE: SVB Leerink On Humana Outperform Initiation: Firm Believes Near-Term Concerns Of Rebounding Medical & COVID Costs Are Priced In; Sees Accelerating Growth Environment With FY22 Inflection & Closing Valuation Spread With UnitedHealth Group

Benzinga - Sep 27, 2021, 10:31AM

SVB Leerink Initiates Coverage On UnitedHealth Group with Outperform Rating, Announces Price Target of $480

Benzinga - Sep 27, 2021, 6:18AM

UnitedHealthCare To Offer Members Access To Apple Fitness+

Benzinga - Sep 23, 2021, 11:29AM

'Fast Money Halftime Report' Picks For AbbVie, UnitedHealth And More

Benzinga - Sep 1, 2021, 5:09PM

Exact Sciences Shares See Volume, Traders Circulate UnitedHealthCare Report Highlighting Updated Preventive Care Services Policy Lowered Age For Colorectal Cancer Screening From 50-75 To 45-75; BZ Note: Exact Sciences Has Cologuard Screening Service

Benzinga - Sep 1, 2021, 12:14PM

Morgan Stanley Maintains Overweight on UnitedHealth Group, Lowers Price Target to $488

Benzinga - Aug 31, 2021, 7:51AM

'24/Hr' UNH Trade

Benzinga - Jul 27, 2021, 10:18AM

load more

Sector: Health Care.Industry: Health Care Providers & Services

UnitedHealth Group is the largest private health insurance provider in the United States, providing medical benefits to 48 million members across its U.S. and international businesses at the end of 2020. As a leader in employer-sponsored, self-directed, and government-backed insurance plans, UnitedHealth has obtained massive scale in managed care. Along with its insurance assets, UnitedHealth's continued investments in its Optum franchises have created a healthcare services colossus that spans everything from medical and pharmaceutical benefits to providing outpatient care and analytics to both affiliated and third-party customers.

Earnings

Q4 2021		Est.		Actual		Surprise
EPS		(EXPECTED)2022-01-19
REV		(EXPECTED)2022-01-19

Q3 2021		Est.		Actual		Surprise
EPS		4.410		4.520		0.1100
REV		71.190B		72.337B		1.147B

Analyst Ratings

Date	Analyst Firm	Analyst Name	Action	Rating	Action Price	Prior Price	Target

UnitedHealth Group Questions & Anwsers

Q

How do I buy UnitedHealth Group (UNH) stock?

A

You can purchase shares of UnitedHealth Group (NYSE: UNH) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are UnitedHealth Group's (UNH) competitors?

A

Other companies in UnitedHealth Group’s space includes: HealthEquity (NASDAQ:HQY), Humana (NYSE:HUM), Molina Healthcare (NYSE:MOH), Progyny (NASDAQ:PGNY) and Triple-S Management (NYSE:GTS).

Q

What is the target price for UnitedHealth Group (UNH) stock?

A

The latest price target for UnitedHealth Group (NYSE: UNH) was reported by Wells Fargo on October 25, 2021. The analyst firm set a price target for 520.00 expecting UNH to rise to within 12 months (a possible 14.38% upside). 32 analyst firms have reported ratings in the last year.

Q

Current Stock Price for UnitedHealth Group (UNH)?

A

The stock price for UnitedHealth Group (NYSE: UNH) is $454.635 last updated Tue Oct 26 2021 20:00:03 GMT+0000 (Coordinated Universal Time).

Q

Does UnitedHealth Group (UNH) pay a dividend?

A

There are no upcoming dividends for UnitedHealth Group. The last dividend paid out to investors was $0.01 on September 10, 2021.

Q

When is UnitedHealth Group (NYSE:UNH) reporting earnings?

A

UnitedHealth Group’s $Q4 earnings are confirmed for after-market on $January 19, 2022.

Q

Is UnitedHealth Group (UNH) going to split?

A

There is no upcoming split for UnitedHealth Group.

Q

What sector and industry does UnitedHealth Group (UNH) operate in?

A

UnitedHealth Group is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NYSE.